Europe
Here are three biopharma stocks worth keeping an eye on.
The medtech titan was told to make a public apology and remove the content.
In the world of Alzheimer’s disease research, the names of some companies attempting to find an efficacious therapy stand out.
The portfolio consists of acute, chronic and oncology products.
A cybersecurity expert said the error may leave people vulnerable to hackers.
A look at why these two biopharma companies could have targets on their backs.
Here is a look at key takeaways from presentations made by four major pharma and biotech stocks at the annual J.P. Morgan healthcare conference.
Novartis has found its new chief of oncology.
Dr. Erwin Erfe, head of the PAO Forensic Laboratory, said the 4 children they examined contracted dengue 6 months after receiving the vaccine.
Nestle submitted the highest offer and Merck was likely to select a winner during the first quarter, but might also choose not to sell the assets after all.
PRESS RELEASES